These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 31367535)

  • 1. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis.
    Wang Z; Zhan P; Lv Y; Shen K; Wei Y; Liu H; Song Y
    Transl Lung Cancer Res; 2019 Jun; 8(3):214-226. PubMed ID: 31367535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the neutrophil to lymphocyte ratio and clinical outcomes in patients with lung cancer receiving immunotherapy: a meta-analysis.
    Jin J; Yang L; Liu D; Li W
    BMJ Open; 2020 Jun; 10(6):e035031. PubMed ID: 32499266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs).
    Li Y; Zhang Z; Hu Y; Yan X; Song Q; Wang G; Chen R; Jiao S; Wang J
    Front Oncol; 2020; 10():654. PubMed ID: 32656072
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
    Zhang N; Jiang J; Tang S; Sun G
    Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
    Peng H; Luo X
    Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
    Leng J; Wu F; Zhang L
    Front Oncol; 2022; 12():734948. PubMed ID: 35651788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
    Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
    BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis.
    Jiang T; Qiao M; Zhao C; Li X; Gao G; Su C; Ren S; Zhou C
    Cancer Immunol Immunother; 2018 May; 67(5):713-727. PubMed ID: 29423649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis.
    Matsas S; Aguiar PN; Del Giglio A
    J Gastrointest Oncol; 2024 Feb; 15(1):33-51. PubMed ID: 38482212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    Chen X; Meng F; Jiang R
    Front Oncol; 2021; 11():746976. PubMed ID: 34900692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients.
    Zhao QT; Yang Y; Xu S; Zhang XP; Wang HE; Zhang H; Wang ZK; Yuan Z; Duan GC
    Onco Targets Ther; 2015; 8():2731-8. PubMed ID: 26491346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies.
    Cao D; Xu H; Xu X; Guo T; Ge W
    Oncoimmunology; 2018; 7(11):e1507262. PubMed ID: 30377569
    [No Abstract]   [Full Text] [Related]  

  • 13. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Su L; Zhang M; Zhang W; Cai C; Hong J
    Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
    Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
    Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis.
    Sacdalan DB; Lucero JA; Sacdalan DL
    Onco Targets Ther; 2018; 11():955-965. PubMed ID: 29503570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients.
    Yu Y; Qian L; Cui J
    Mol Clin Oncol; 2017 Sep; 7(3):498-506. PubMed ID: 28811903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy.
    Li Y; Meng Y; Sun H; Ye L; Zeng F; Chen X; Deng G
    J Immunother; 2022 Jan; 45(1):43-50. PubMed ID: 34510106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis.
    Peng B; Wang YH; Liu YM; Ma LX
    Int J Clin Exp Med; 2015; 8(3):3098-106. PubMed ID: 26064198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
    Lu Y; Jiang J; Ren C
    PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.